Loading...
-
OranssiBio’s Commitment:
Propelling Excellence through Exceptional Development and GMP Manufacturing Services, Establishing New Industry Benchmarks
-
OranssiBio’s Commitment:
Empowering Patient Access to Life-Saving Cell and Gene Therapies
-
OranssiBio’s Commitment:
Comprehensive Solutions: Your Trusted Companion for Discovery, Clinical Development, and Commercialization Endeavors
-
OranssiBio’s Commitment:
Unyielding Commitment to Quality: Ensuring Global Compliance and Adherence to Industry-Leading Best Practices
Our Team
Our experienced management team boasts an average of 20 years of expertise in technical and managerial roles, with a proven track record in developing and globally regulatory filing for cell and gene products, mABs, and small molecules.
Our Facility
OranssiBio’s facility operates in full compliance with US/EU standards for GMP and other stringent quality requirements.
Leveraging well-established and cutting-edge research and manufacturing platforms, OranssiBio encompasses a diverse range of technologies, including exosomes, adeno-associated virus, lenti virus, cell, and plasmid DNA, among others.
Additionally, OranssiBio is supported by a comprehensive analytical support system and a well-established “Drugability Screening System.”
